Dabigatran versus warfarin: Effects on ischemic and hemorrhagic strokes and bleeding in asians and non-Asians with atrial fibrillation

by Masatsugu Hori, Stuart J. Connolly, Jun Zhu, Li Sheng Liu, Chu Pak Lau, Prem Pais, Denis Xavier, Sung Soon Kim, Razali Omar, Antonio L. Dans, Ru San Tan, Jyh Hong Chen, Supachai Tanomsup, Mitsunori Watanabe, Masahide Koyanagi, Michael D. Ezekowitz, Paul A. Reilly, Lars Wallentin, Salim Yusuf
Published 2018

Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: An RE-LY AF registry analysis

by Mariëlle Kloosterman, Jonas Oldgren, David Conen, Jorge A. Wong, Stuart J. Connolly, Alvaro Avezum, Salim Yusuf, Michael D. Ezekowitz, Lars Wallentin, Marie Ntep-Gweth, Philip Joseph, Tyler W. Barrett, Supachai Tanosmsup, William F. McIntyre, Shun Fu Lee, Ratika Parkash, Guy Amit, Alex Grinvalds, Isabelle C. Van Gelder, Jeff S. Healey
Published 2020

The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) study

by Stuart J. Connolly, Lars Wallentin, Michael D. Ezekowitz, John Eikelboom, Jonas Oldgren, Paul A. Reilly, Martina Brueckmann, Janice Pogue, Marco Alings, John V. Amerena, Alvaro Avezum, Iris Baumgartner, Andrzej J. Budaj, Jyh Hong Chen, Antonio L. Dans, Harald Darius, Giuseppe Di Pasquale, Jorge Ferreira, Greg C. Flaker, Marcus D. Flather, Maria Grazia Franzosi, Sergey P. Golitsyn, David A. Halon, Hein Heidbuchel, Stefan H. Hohnloser, Kurt Huber, Petr Jansky, Gabriel Kamensky, Matyas Keltai, Sung Soon Kim, Chu Pak Lau, Jean Yves Le Heuzey, Basil S. Lewis, Lisheng Liu, John Nanas, Razali Omar, Prem Pais, Knud E. Pedersen, Leopoldo S. Piegas, Dimitar Raev, Pal J. Smith, Mario Talajic, Ru San Tan, Supachai Tanomsup, Lauri Toivonen, Dragos Vinereanu, Denis Xavier, Jun Zhu, Susan Q. Wang, Christine O. Duffy, Ellison Themeles, Salim Yusuf
Published 2018